首页|肠道菌群调控动物肠道黏膜免疫和炎症的研究进展

肠道菌群调控动物肠道黏膜免疫和炎症的研究进展

扫码查看
肠道菌群的改变可能引起黏膜免疫应答失调,导致遗传易感宿主发生炎症性肠病(inflammation bowel disease,IBD).目前治疗动物IBD的有效方法是通过微生物靶向疗法(包括抗生素、益生元、后生素和粪便微生物群移植)恢复肠道微生物群的正常免疫稳态.本文将讨论通过微生物靶向治疗促进肠道稳态免疫反应的基础,以及IBD发生发展过程中宿主-微生物相互作用的最新进展.考虑到肠道菌群失调是慢性炎症建立的一个关键特征,以期在不久的将来,微生物靶向疗法将适合设计新的具有成本效益的、生理学的、以动物为导向的IBD治疗策略,以个性化的方式应用.
Research Progress in the Regulation of Intestinal Flora on Intestinal Mucosal Immunity and Inflammation in Animals
Alterations of the gut microbiota may cause dysregulated mucosal immune responses,leading to the onset of inflammatory bowel diseases(IBD)in genetically susceptible hosts.Current effective treatments for IBD in animals are restoration of normal immune homeostasis of the gut microbiota by microbiota-targeted therapies including antibiotics,prebiotics,postbiotics,and fecal microbiota trans-plantation.In this review,the basis for promoting intestinal homeostatic immune responses through microbiota-targeted therapy,as well as recent advances in host-microbe interactions during the occur-rence and development of IBD were discussed.Given that dysbacteriosis of the intestinal flora is a key feature in the establishment of chronic inflammatory events,it is hoped that in the near future the micro-biota-targeted therapies will be appropriate to design new cost-effective,physiological,animal-oriented IBD treatment strategies to be applied in a personalized manner.

animalintestinal floramucosal immunityinflammatory bowel diseases

刘思弟、马贲、郑言、邱云桥、姚泽龙、曹中赞、栾新红

展开 >

沈阳农业大学动物科学与医学学院,沈阳 110161

动物 肠道菌群 黏膜免疫 炎症性肠病

国家自然科学基金国家自然科学基金国家自然科学基金

322729533207281032372956

2024

畜牧兽医学报
中国畜牧兽医学会

畜牧兽医学报

CSTPCD北大核心
影响因子:0.729
ISSN:0366-6964
年,卷(期):2024.55(4)
  • 88